At Epimeron our business is to enable the commercialization of high-value bioproducts. We achieve this by making and deploying key discoveries in plant genomics and pathway biochemistry on behalf of our Synthetic Biology partners. Newly discovered genetic elements and biochemical mechanisms are transferred or translated into an appropriate industrial host organism, and optimized for maximum yield. Because we own rather than license the intellectual property we develop, we are able to enter into mutual beneficial licensing agreements with our corporate partners. For Epimeron, the mission is to enable the modernization of high-value plant bioproduct manufacturing methods. We invite you to partner with us, and we look forward to enhancing the success of your manufacturing projects.